@ARTICLE{
author={Hanauer Stephen B,...,Sreckovic Slobodan,...,(broj koautora 33)},
year={2024},
title={Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)},
journal={GASTROENTEROLOGY},
volume={167},
number={5},
pages={919-933},
document_type={Article; Proceedings Paper},
} 

@ARTICLE{
author={Danese Silvio,Feagan Brian G,Hanauer Stephen B,Jovanovic Igor,Ghosh Subrata,Petersen Ann Katrin,Hua Steven,Lee Hwan Ji,Charles Lorna,Chitkara Denesh,Sandborn William J,D'Haens Geert},
year={2020},
title={Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Maintenance in the Phase 3 True North Study},
journal={AMERICAN JOURNAL OF GASTROENTEROLOGY},
volume={115},
number={},
pages={S8-S8},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Sandborn William J,D'Haens Geert,Wolf Doug,Hanauer Stephen B,Jovanovic Igor,Ghosh Subrata,Petersen Ann Katrin,Hua Steven,Lee Hwan Ji,Charles Lorna,Usiskin Keith,Danese Silvio,Feagan Brian G},
year={2020},
title={Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study},
journal={AMERICAN JOURNAL OF GASTROENTEROLOGY},
volume={115},
number={},
pages={S6-S7},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Danese Silvio,Feagan Brian G,Hanauer Stephen B,Jovanovic Igor,Ghosh Subrata,Petersen AnnKatrin,Hua Steven,Lee Hwan Ji,Charles Lorna,Chitkara Denesh,Sandborn William J,D'Haens Geert},
year={2020},
title={Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension},
journal={AMERICAN JOURNAL OF GASTROENTEROLOGY},
volume={115},
number={},
pages={S8-S8},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Sandborn William J,D'Haens Geert,Wolf Doug,Hanauer Stephen B,Jovanovic Igor,Ghosh Subrata,Petersen Ann Katrin,Hua Steven,Lee Hwan Ji,Charles Lorna,Usiskin Keith,Danese Silvio,Feagan Brian G},
year={2020},
title={Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study},
journal={AMERICAN JOURNAL OF GASTROENTEROLOGY},
volume={115},
number={},
pages={S6-S7},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Sandborn William J,Regula Jaroslaw,Feagan Brian G,Belousova Elena,Jojic Njegica Z,Lukas Milan,Yacyshyn Bruce,Krzeski Piotr,Yeh Chyon-Hwa,Messer Christi A,Hanauer Stephen B},
year={2009},
title={Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis},
journal={GASTROENTEROLOGY},
volume={137},
number={6},
pages={1934-1943},
document_type={Article},
} 

@ARTICLE{
author={Rossi Claudia Pena,Hanauer Stephen B,Tomasevic Ratko S,Hunter John O,Shafran Ira,Graffner Hans},
year={2009},
title={Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study},
journal={BMC GASTROENTEROLOGY},
volume={9},
number={},
pages={-},
document_type={Article},
}